Forecast Of The Day: GE’s Healthcare Equipment Revenue
What?
GE’s (NYSE:GE) Healthcare Equipment Revenue declined from around $11.5 billion in 2019 to about $9.8 billion in 2020. Trefis expects the number to decline further to around $9.5 billion in 2021 although it should recover to around $9.8 billion in 2022.
Why?
- What’s Next For General Electric Stock After A 35% Rise This Year?
- What’s Next For General Electric Stock After 70% Gains In A Year?
- Down 20% This Year Is RTX Stock A Better Pick Than General Electric?
- Should You Pick General Electric Stock At $110 After A Solid Q3?
- After An 18% Top-Line Growth In Q2 Will General Electric Stock Deliver Another Strong Quarter?
- Is General Electric Stock A Better Pick Over Its Sector Peer?
While sales were impacted due to the Covid-19 pandemic, we expect longer-term growth to be driven by the company’s market-leading products and higher demand from emerging economies.
So What?
While GE’s stock price has almost doubled over the last 12 months, driven by an improving growth outlook for its aviation and healthcare operations, we think it still remains undervalued. We value GE at about $117 per share, a premium of around 17% over the current market price.
See Our Complete Analysis For General Electric
